Rusnanta F. Sodium-Glucose Co-Transporter 2 Inhibitor in Acute Heart Failure: The Booster of Decongestive Therapy?. Heart Sci He
![Healthcare | Free Full-Text | SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials Healthcare | Free Full-Text | SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials](https://pub.mdpi-res.com/healthcare/healthcare-10-02356/article_deploy/html/images/healthcare-10-02356-g001-550.jpg?1669217816)
Healthcare | Free Full-Text | SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
![Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week | Journal of the American College of Cardiology Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/50679703-e6c3-40c0-b508-a1597d38ad83/gr3.jpg)
Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week | Journal of the American College of Cardiology
![Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week - ScienceDirect Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109722045661-fx1.jpg)
Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week - ScienceDirect
![JCM | Free Full-Text | Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure JCM | Free Full-Text | Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure](https://www.mdpi.com/jcm/jcm-10-03540/article_deploy/html/images/jcm-10-03540-g001-550.jpg)
JCM | Free Full-Text | Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqxtmrUUAcd32Y.jpg)
rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqxG0GVIAIIpSB.jpg)
rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter
![Enrique Santas on Twitter: "Tras los excelentes resultados de dapagliflozina en DAPA-HF y la aprobación de su indicación en HFrEF. Útil en IC aguda? 👇 🔖 Estudio DICTATE-AHF 🔖 Dapagliflozina vs placebo Enrique Santas on Twitter: "Tras los excelentes resultados de dapagliflozina en DAPA-HF y la aprobación de su indicación en HFrEF. Útil en IC aguda? 👇 🔖 Estudio DICTATE-AHF 🔖 Dapagliflozina vs placebo](https://pbs.twimg.com/media/EmFpt0nWMAYZKaZ.jpg:large)
Enrique Santas on Twitter: "Tras los excelentes resultados de dapagliflozina en DAPA-HF y la aprobación de su indicación en HFrEF. Útil en IC aguda? 👇 🔖 Estudio DICTATE-AHF 🔖 Dapagliflozina vs placebo
![rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter](https://pbs.twimg.com/media/FBqyE2AVEBA4z1e.jpg)
rafavidalperez on Twitter: "More information coming DAPA ACT HF - TIMI 68 #HeartFailure @SOGACAR_ #ACorunaHF2021 https://t.co/JqXL2LOcRq" / Twitter
![Cumulative incidence of HF hospitalization in EMPAREG-OUTCOME (reproduced | Download Scientific Diagram Cumulative incidence of HF hospitalization in EMPAREG-OUTCOME (reproduced | Download Scientific Diagram](https://www.researchgate.net/publication/348989799/figure/fig1/AS:1024900051513345@1621366622482/Cumulative-incidence-of-HF-hospitalization-in-EMPAREG-OUTCOME-reproduced_Q640.jpg)